SMS Lifesciences Share Price

SMS Lifesciences Share Price

NSE: HALEOSLABS
|
Pharmaceuticals

₹ 1,550.00

-₹13.10 (-0.84%)
1D
Last updated 13 Oct, 2026, 15:29 IST

SMS Lifesciences Share Price Today

As of 13 Oct 2026, SMS Lifesciences share price is ₹1,550.00. The stock opened at ₹1,555.20, compared to its previous close of ₹1,563.10. During today's trading session, SMS Lifesciences share price moved in the range of ₹1,540.00 to ₹1,580.00, with an average price of ₹1,560.00 for the day. Looking at its last 52-week, the stock has touched a low of ₹1,091.10 and a high of ₹1,774.00. On the performance front, SMS Lifesciences share price has increased by 20.94% over the last six months and is up 37.38% on a year-on-year basis.

₹1,540.00
0.84% down today
₹1,580.00
1D LOW
1D HIGH

SMS Lifesciences Returns Calculator

Volume
1,257
Average traded price
₹1,558.64
Last traded time
03:29:45 13 Oct
Last traded quantity
100
Circuit
L
H
₹1,250.50
₹1,875.70
52-week
L
H
₹1,091.10
₹1,774.00
Mkt Cap Cr
484.45
P/E
31.75
P/B
2.27
ROA
3.36%
ROE
8.11%
ROCE
9.76%
Quick Ratio
0.53
EV/EBITDA
13.21
Based on fundamentals, this stock's
Step 5 of 5
Performance
Excellent
Haleos Labs Limited outperforming all market indices
Step 1 of 5
Valuation
Overvalued
Haleos Labs Limited appears overvalued compared to its peers
Step 3 of 5
Earnings
Neutral
Haleos Labs Limited earnings growth is positive
Peer Comparison
Peer comparison — key ratios
NameMkt Cap CrP/EP/BROAROEROCEQuick RatioEV/EBITDA
Sun Pharmaceutical Industries4,22,067.0134.835.0511.19%13.74%17.33%2.3121.42
Divis Laboratories2,48,982.9885.1214.8514.6%15.32%19.56%3.556.28
Torrent Pharmaceuticals1,77,251.4282.5521.164.87%25.49%13.85%0.7538.11
Zydus Lifesciences1,13,615.6924.744.198.57%18.59%17.35%0.9114.87
Laurus Labs1,11,898.66102.6321.1110.38%16.77%16.14%0.6853.86
Cipla1,06,129.9631.623.087.92%11.27%14.95%2.517.83
Dr. Reddy's Laboratories1,02,707.4132.262.75.48%11.07%12.54%1.3515.86
Mankind Pharma99,089.5247.926.087.36%11.74%13.13%0.7425.7
Aurobindo Pharma97,972.4726.42.596.34%9.25%11.76%1.1512.47
Lupin89,628.8316.033.9614.47%23.76%24.88%1.429.56

Auto-generated based on historical fundamentals; not a recommendation to buy/sell.

About SMS Lifesciences

SMS Lifesciences Share Price
ISIN
INE320X01016
Sector Market Cap
₹ 484.45 Cr

Haleos Labs Limited, formerly, SMS Lifesciences India Limited, is an India-based company that is engaged in the business of manufacturing of active pharma ingredients (API) and their intermediates. The Company's API products include Ranitidine Hydrochloride (Form-2) USP / Ph. Eur / IP, Famotidine USP / Ph. Eur / IP, Sildenafil Citrate USP / Ph. Eur / IP, Allopurinol USP / EP / IP, Ropivacaine Hydrochloride USP / EP / IP, Dapsone USP/ EP /BP, Sibutramine Hydrochloride USP, Itraconazole USP / Ph. Eur, Fosphenytoin Sodium USP, Domperidone / Domperidone Maleate EP / IP, Brinzolamide, Tiagabine, Fosaprepitant and Albendazole, among others. Its intermediate offerings include Ranitidine HCl Intermediates, Rizatriptan Intermediates and Imidapril Intermediates. The Company's manufacturing facilities are located at Kazipally and Jeedimetla, and its research and development center is at Sanath Nagar in Hyderabad. The Company's wholly owned subsidiary is Mahi Drugs Private Limited.

SMS Lifesciences Financial Highlights

  • Revenue: SMS Lifesciences reported revenue of ₹336.22 crore in FY26 vs ₹349.58 crore in FY25. It showed a decrease of 3.82% on a yearly basis.
  • Operating Profit: SMS Lifesciences reported an operating profit of ₹25.20 crore in FY26 vs ₹26.19 crore in FY25. It showed a decrease of 3.78% on a year-on-year basis.
  • Net Profit: SMS Lifesciences reported a net profit of ₹17.80 crore in FY26 vs ₹18.73 crore in FY25. It showed a decrease of 4.97% on a yearly basis.

SMS Lifesciences Quarterly Result Highlights

  • SMS Lifesciences reported revenue of ₹73.40 crore in Jun 2026, compared with ₹77.15 crore in Mar 2026, representing a decrease of 4.86% on a quarter-on-quarter (QoQ) basis.
  • SMS Lifesciences reported an operating profit of ₹3.44 crore in Jun 2026, compared with ₹0.91 crore in Mar 2026, representing an increase of 278.02% on a quarter-on-quarter (QoQ) basis.
  • SMS Lifesciences reported a profit of ₹1.84 crore in Jun 2026, compared with ₹0.34 crore in Mar 2026, reflecting an increase of 441.18% on a QoQ basis.
  • The earnings per share (EPS) of SMS Lifesciences stood at ₹66.51 during Jun 2026.

Data Source: BSE, Company announcements

Securities shown are illustrative, not recommendations. Past performance does not guarantee future results.

Know more
Promoters
72.11%
FII
0.00%
Other DII
0.31%
Retail and other
27.58%
Mutual funds
0.00%
Foreign Institutional Investor (FII)
FII shareholding by period
Sep 20250.00%
Dec 20250.00%
Mar 20260.00%
Jun 20260.00%
1 day
-1.09%
1 week
-2.63%
1 month
+5.72%
1 year
+37.38%
3 years
+199.46%
5 years
+91.85%
Day
Open / Close
Change %
12 Oct 26
₹1,540.40 / ₹1,563.10
-0.04%
09 Oct 26
₹1,597.40 / ₹1,563.70
-0.26%
08 Oct 26
₹1,590.00 / ₹1,567.80
-1.07%
07 Oct 26
₹1,590.00 / ₹1,584.70
-0.20%
Show more

SMS Lifesciences Financials

Full statement

Income Statement · Consolidated

Income Statement · Consolidated — all values in INR Crore
ParticularsMar 2025Mar 2024Mar 2023Mar 2022
Revenue₹344.72₹305.96₹315.56₹350.07
Other Income₹4.86₹3.83₹3.07₹1.74
Total Revenue₹349.58₹309.79₹318.63₹351.81
Total Expenses₹323.39₹299.94₹304.39₹331.77
Profit Before Tax₹26.19₹9.85₹16.59₹32.73
Tax₹7.46₹3.52₹5.22₹7.43
Profit After Tax₹18.73₹6.33₹11.38₹25.30
EPS - Basic₹66.51₹30.08₹37.92₹83.76
EPS - Diluted₹66.51₹30.08₹37.92₹83.76

Cash Flow · Consolidated

Cash Flow · Consolidated — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Profit before tax₹25.20₹26.19₹9.85₹14.24
Income before WC changes₹42.87₹50.91₹31.33₹30.11
Change in Assets-₹55.26-₹49.93-₹40.32-₹31.16
Change in Liabilities₹56.11₹41.57₹36.30₹19.01
Change in WC₹0.85-₹8.36-₹4.03-₹12.15
Cash flow from Operations₹37.22₹34.05₹24.31₹14.70
Cash flow from Investing-₹57.90-₹15.00-₹18.45-₹31.29
Cash flow from Financing₹21.38-₹19.12-₹6.56₹16.89
Total Cash Flow₹0.71-₹0.07-₹0.71₹0.29
Cash (Start of the year)₹0.50₹0.57₹1.28₹0.99
Cash (End of the year)₹1.21₹0.50₹0.57₹1.28

Balance Sheet · Consolidated

Balance Sheet · Consolidated — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Non-Current Assets--₹239.42₹235.25₹235.77
Current Assets--₹150.57₹156.08₹159.12
Total Assets--₹389.99₹391.33₹394.89
Current Liabilities--₹142.07₹145.37₹133.56
Net Current Asset--₹8.51₹10.71₹25.55
Non-Current Liabilities--₹35.88₹52.32₹73.11
Equity Capital--₹212.05₹193.64₹188.22
Total Equity & Liabilities--₹389.99₹391.33₹394.89

Income Statement · Standalone

Income Statement · Standalone — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Revenue₹300.99₹333.37₹300.00₹315.24
Other Income₹1.42₹3.95₹3.84₹2.88
Total Revenue₹302.41₹337.32₹303.84₹318.12
Total Expenses₹277.22₹307.28₹284.73₹302.10
Profit Before Tax₹25.19₹30.04₹19.11₹18.37
Tax₹7.41₹8.67₹6.05₹5.15
Profit After Tax₹17.78₹21.37₹13.07₹13.22
EPS - Basic₹58.80₹70.69₹43.22₹43.72
EPS - Diluted₹58.80₹70.69₹43.22₹43.72

Cash Flow · Standalone

Cash Flow · Standalone — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Profit before tax₹25.19₹30.04₹19.11₹16.02
Income before WC changes₹37.60₹48.89₹34.51₹27.53
Change in Assets-₹2.85-₹9.82-₹6.97-₹7.49
Change in Liabilities₹10.18-₹2.54-₹9.79-₹11.97
Change in WC₹7.33-₹12.36-₹16.76-₹19.45
Cash flow from Operations₹38.43₹28.03₹14.75₹4.58
Cash flow from Investing-₹49.28-₹13.77-₹13.75-₹27.96
Cash flow from Financing₹10.85-₹14.20-₹0.82₹22.59
Total Cash Flow₹0.00₹0.07₹0.18-₹0.80
Cash (Start of the year)₹0.40₹0.33₹0.15₹0.95
Cash (End of the year)₹0.40₹0.40₹0.33₹0.15

Balance Sheet · Standalone

Balance Sheet · Standalone — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Non-Current Assets₹221.63₹180.52₹172.88₹169.80
Current Assets₹181.71₹177.79₹175.35₹167.59
Total Assets₹403.34₹358.31₹348.24₹337.39
Current Liabilities₹133.02₹124.30₹123.56₹110.57
Net Current Asset₹48.69₹53.49₹51.79₹57.03
Non-Current Liabilities₹55.74₹36.84₹48.45₹62.80
Equity Capital₹214.58₹197.18₹176.23₹164.03
Total Equity & Liabilities₹403.34₹358.31₹348.24₹337.39
* All values are in INR Crore
Qty
Bid
0
0
0
0
0
0
0
0
0
0
Ask
Qty
1546.1
1
0
0
0
0
0
0
0
0
Bid Total: 0
Ask Total: 1
Buy orders: 0%
Sell orders: 100%
Bearish
1
Neutral
6
Bullish
1
Neutral
by SEBI experts
Expert Pick
EXPPICK
Stop-loss
Entry price
Target
Indicator
Value
Verdict
RSI (14)
60.42
Neutral
ATR (14)
49.4
Neutral
STOCH(9,6)
76.73
Neutral
STOCH RSI (14)
63.69
Neutral
ADX(9)
25.55
Bearish
UO(9)
60.76
Neutral
ROC(12)
3.47
Bullish
WillR(14)
-23.27
Neutral
Period
Simple value
Exponential vaue
5D
1573.42
1561.25
10D
1540.91
1546.86
20D
1518.13
1526.81
50D
1494.23
1507.67
100D
1504.8
1484.4
Volume trend — traded volume by day
13 Oct0L
12 Oct0L
9 Oct0L
8 Oct0L
7 Oct0L
6 Oct0L
Average0L

Technical indicators used here are for indicative purposes only. Kindly do not treat it as an investment or trading advice

Compare against other stocks
SMS Lifesciences Share Price
SMS Lifesciences
Pharmaceuticals
Add Stock
Add Another

SMS Lifesciences Share Price FAQs

Disclaimer: The information on this page, including prices, charts, financials, ratios, and other data, is provided for informational and educational purposes only. It is not investment advice, a research report, or a recommendation or solicitation to buy, sell, or hold any security. Data is sourced from third parties and exchanges, may be delayed, and is not guaranteed to be accurate, complete, or timely. Upstox is not liable for any loss arising from its use.